bluebird bio Stock Discussion

$bluebird bio (BLUE.US)$ Carlyle and SK Capital Partners announced the extension of their tender offer for bluebird bio from April 4 to April 18, 2025. The extension aims to allow additional time for satisfying remaining conditions, including regulatory approvals. As of April 2, approximately 65,120 shares have been validly tendered.
The offer includes $3.00 in cash per share plus one contingent value right (CVR) representing a potential additional payment of $6.84 per share, subjec...

$bluebird bio (BLUE.US)$
🚀🚀

$bluebird bio (BLUE.US)$ Reuters· just
Xcellbio: Granted bluebird bio Commercial License, Got Into Supply Agreement for Use of Co's Proprietary Cell Manufacturing Technology, Avatar

Here are the levels to watch as Blue pushes higher.
$bluebird bio (BLUE.US)$  

$bluebird bio (BLUE.US)$ close my eyes it'll rise

$bluebird bio (BLUE.US)$ damn i didnt buy it when 4.6

$bluebird bio (BLUE.US)$
🚀😉

$bluebird bio (BLUE.US)$
good earning recently with a little bump 👀

$bluebird bio (BLUE.US)$ bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
SOMERVILLE, Mass.—(BUSINESS WIRE)—March 28, 2025— bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal (the “Ayrmid Proposal”) from Ayrmid Ltd (“Ayrmid”) to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right...

$bluebird bio (BLUE.US)$
Bluebird Gets New M&A Bid, Seeking To Top Private Equity Offer' - Endpoints News